CMV IgM ELISA Kit (Cytomegalovirus)

Full Name: CMV IgM ELISA Kit (Cytomegalovirus)
Reactivity: Human
Sample Type: Plasma, Serum
Sensitivity: 1.14 U/ml


Cytomegalovirus (CMV) are herpesvirus infections that can display many symptoms and are easily spread through non-sexual and sexual contact with body secretions. These infection can frequently develop in people who receive an infected organ transplant or transfusion of infected blood. The fetus of an infected pregnant woman may also acquire this infection during the pregnancy or even at the time of delivery.

The virus tends to infect the retina of the eye, brain (encephalitis), pneumonia or even painful ulcers of the oesophagus and the intestine may develop. Blood tests can be carried out to detect antibodies to CMV, this will only confirm new infections but cannot confirm if a disease is due to reactivation of the virus (majority of cases for people with weak immune systems). Cytomegalovirus-retinitis can be confirmed by an ophthalmologist and in newborns, the favoured option for the diagnosis is by culturing the urine.


Human CMV IgM ELISA kit is intended for detecting in-vitro amounts of human IgM antibodies to cytomegalovirus (CMV, CMV-IgM) using serum or plasma samples. This assay has a minimum analytical sensitivity limit of 1.14 U/ml.


All reagents supplied need to be stored at 2 °C – 8 °C, unopened reagents will retain reactivity until expiration date. Do not use reagents beyond this date.

  • Cytomegalovirus antigen coated microtiter strips.
  • Calibrator D (Positive Control).
  • Calibrator C (Weak Positive Control).
  • Calibrator B (Cut-Off Standard).
  • Calibrator A (Negative Control).
  • Enzyme Conjugate.
  • Sample Diluent.
  • TMB Substrate.
  • Washing Buffer (10x).
  • Stop Solution.


The minimum detection sensitivity level of human  IgM against cytomegalovirus (CMV-IgM) using current CMV IgM ELISA kit was 1.29 U/ml. The dynamic range for this assay is 1.0 – 120.0 U/ml.


– Intra-Assay-Precision: 9.9 – 13.8 %
– Inter-Assay-Precision: 2.7 – 26.6 %
– Inter-Lot-Precision: 1.2 – 22.7 %
– Analytical Sensitivity: 1.14 U/mL
– Recovery: 100 – 110 %
– Linearity: 72 – 117 %
– Cross-Reactivity: No cross-reactivity to rubella, parainfluenza, measles, herpes 1, mumps, toxoplasma, EBV-VCA and varicella.
– Interferences: No interferences.
– Clinical Specificity: 98 %
– Clinical Sensitivity: 100 %


  1. Dual-labeled time-resolved immunofluorometric assay for the determination of IgM antibodies to rubella virus and cytomegalovirus in human serum. Clin Biochem. (2015) 48 (9): 603-8. Zhou J.W., et al.
  2. Maternal IgM antibody status in confirmed fetal cytomegalovirus-infection detected by sonographic signs. Prenat Diagn. (2012) 32 (9): 817-21. Goncé A., et al.
  3. Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM. J Clin Microbiol. (1998) 36 (11): 3337-41. Lazzarotto T., et al.
  4. Comparison of five CMV IgM immunoassays with CMV IgG avidity for diagnosis of primary CMV infection. Pathology. (2012) 44 (4): 381-3. BaAlawi F., et al.
  5. Positive Epstein-Barr virus and cytomegalovirus IgM assays in primary HIV infection. J Med Virol. (2011) 83 (8): 1406-9. Post J.J., et al.


Online Enquiry Form

"*" indicates required fields

Please check mark information required:


Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford